Skip to main content
Top
Published in: World Journal of Surgery 9/2018

01-09-2018 | Original Scientific Report

Is Partial or Total Thyroidectomy Associated with Risk of Long-Term Osteoporosis: A Nationwide Population-Based Study

Authors: Chien-Ling Hung, Chih-Ching Yeh, Pi-Shan Sung, Chung-Jye Hung, Chih-Hsin Muo, Fung-Chang Sung, I-Ming Jou, Kuen-Jer Tsai

Published in: World Journal of Surgery | Issue 9/2018

Login to get access

Abstract

Background

Whether thyroidectomy contributes to osteoporosis (OP) and osteoporotic fracture (OF) is a subject of debate. This study aimed to determine the effect of thyroidectomy on the risk of OP and OF.

Methods

This retrospective cohort study is based on patient data between January 2000 to December 2005 from the National Health Insurance Research Database. Patients who underwent thyroidectomy were enrolled in the thyroidectomy cohort, and the control cohort was selected by propensity score matching at a ratio of 1:4. Incident OP and OF cases were identified until the end of 2013. The thyroidectomy cohort to control cohort adjusted hazard ratio (aHR) for OP/OF was assessed through multivariable Cox proportional hazard regression analysis.

Results

Totals of 1426 and 5704 patients were included in the thyroidectomy and control cohorts, respectively. The incidence density of OP was higher in the thyroidectomy cohort (7.91/1000 person-years) than in the control cohort (5.98/1000 person-years), with an aHR of 1.43 (95% CI 1.16–1.77, p < 0.05). Younger patients, women, and patients with comorbidities were at a higher risk. The risks of postoperative OP/OF were significantly increased in patients who received thyroxine treatment for more than 1 year, both in the partial thyroidectomy group and in the total and subtotal thyroidectomy group (aHR: 2.47, 95% CI: 1.42–2.31 vs. aHR: 1.84, 95% CI: 1.22–2.76).

Conclusion

Thyroidectomy significantly increased the long-term risk of OP. Younger patients, women, patients with comorbidities, and patients receiving chronic thyroxin treatment should be monitored for changes in postoperative bone density.
Literature
1.
go back to reference Tunca F, Senyurek YG, Terzioglu T et al (2009) Impact of total versus subtotal thyroidectomy on calcium metabolism and bone mineral density in premenopausal women. J Laryngol Otol 123:434–438CrossRefPubMed Tunca F, Senyurek YG, Terzioglu T et al (2009) Impact of total versus subtotal thyroidectomy on calcium metabolism and bone mineral density in premenopausal women. J Laryngol Otol 123:434–438CrossRefPubMed
2.
go back to reference Schneider P, Berger P, Kruse K et al (1991) Effect of calcitonin deficiency on bone density and bone turnover in totally thyroidectomized patients. J Endocrinol Invest 14:935–942CrossRefPubMed Schneider P, Berger P, Kruse K et al (1991) Effect of calcitonin deficiency on bone density and bone turnover in totally thyroidectomized patients. J Endocrinol Invest 14:935–942CrossRefPubMed
3.
go back to reference Nguyen TT, Heath H 3rd, Bryant SC et al (1997) Fractures after thyroidectomy in men: a population-based cohort study. J Bone Miner Res 12:1092–1099CrossRefPubMed Nguyen TT, Heath H 3rd, Bryant SC et al (1997) Fractures after thyroidectomy in men: a population-based cohort study. J Bone Miner Res 12:1092–1099CrossRefPubMed
4.
go back to reference Melton LJ 3rd, Ardila E, Crowson CS et al (2000) Fractures following thyroidectomy in women: a population-based cohort study. Bone 27:695–700CrossRefPubMed Melton LJ 3rd, Ardila E, Crowson CS et al (2000) Fractures following thyroidectomy in women: a population-based cohort study. Bone 27:695–700CrossRefPubMed
5.
go back to reference Mirzaei S, Krotla G, Knoll P et al (1999) Possible effect of calcitonin deficiency on bone mass after subtotal thyroidectomy. Acta Med Austriaca 26:29–31PubMed Mirzaei S, Krotla G, Knoll P et al (1999) Possible effect of calcitonin deficiency on bone mass after subtotal thyroidectomy. Acta Med Austriaca 26:29–31PubMed
6.
go back to reference Sugitani I, Fujimoto Y (2011) Effect of postoperative thyrotropin suppressive therapy on bone mineral density in patients with papillary thyroid carcinoma: a prospective controlled study. Surgery 150:1250–1257CrossRefPubMed Sugitani I, Fujimoto Y (2011) Effect of postoperative thyrotropin suppressive therapy on bone mineral density in patients with papillary thyroid carcinoma: a prospective controlled study. Surgery 150:1250–1257CrossRefPubMed
7.
go back to reference Moon JH, Jung KY, Kim KM et al (2016) The effect of thyroid stimulating hormone suppressive therapy on bone geometry in the hip area of patients with differentiated thyroid carcinoma. Bone 83:104–110CrossRefPubMed Moon JH, Jung KY, Kim KM et al (2016) The effect of thyroid stimulating hormone suppressive therapy on bone geometry in the hip area of patients with differentiated thyroid carcinoma. Bone 83:104–110CrossRefPubMed
8.
go back to reference Papaleontiou M, Hawley ST, Haymart MR (2016) Effect of thyrotropin suppression therapy on bone in thyroid cancer patients. Oncologist 21:165–171CrossRefPubMed Papaleontiou M, Hawley ST, Haymart MR (2016) Effect of thyrotropin suppression therapy on bone in thyroid cancer patients. Oncologist 21:165–171CrossRefPubMed
9.
go back to reference Wang LY, Smith AW, Palmer FL et al (2015) Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma. Thyroid 25:300–307CrossRefPubMed Wang LY, Smith AW, Palmer FL et al (2015) Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma. Thyroid 25:300–307CrossRefPubMed
10.
go back to reference Tournis S, Antoniou JD, Liakou CG et al (2015) Volumetric bone mineral density and bone geometry assessed by peripheral quantitative computed tomography in women with differentiated thyroid cancer under TSH suppression. Clin Endocrinol 82:197–204CrossRef Tournis S, Antoniou JD, Liakou CG et al (2015) Volumetric bone mineral density and bone geometry assessed by peripheral quantitative computed tomography in women with differentiated thyroid cancer under TSH suppression. Clin Endocrinol 82:197–204CrossRef
11.
go back to reference Marcocci C, Golia F, Bruno-Bossio G et al (1994) Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women. J Clin Endocrinol Metab 78:818–823PubMed Marcocci C, Golia F, Bruno-Bossio G et al (1994) Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women. J Clin Endocrinol Metab 78:818–823PubMed
12.
go back to reference Kim CW, Hong S, Oh SH et al (2015) Change of bone mineral density and biochemical markers of bone turnover in patients on suppressive levothyroxine therapy for differentiated thyroid carcinoma. J Bone Metab 22:135–141CrossRefPubMedPubMedCentral Kim CW, Hong S, Oh SH et al (2015) Change of bone mineral density and biochemical markers of bone turnover in patients on suppressive levothyroxine therapy for differentiated thyroid carcinoma. J Bone Metab 22:135–141CrossRefPubMedPubMedCentral
13.
go back to reference Vera L, Gay S, Campomenosi C et al (2016) Ten-year estimated risk of bone fracture in women with differentiated thyroid cancer under TSH-suppressive levothyroxine therapy. Endokrynol Pol 67:350–358PubMed Vera L, Gay S, Campomenosi C et al (2016) Ten-year estimated risk of bone fracture in women with differentiated thyroid cancer under TSH-suppressive levothyroxine therapy. Endokrynol Pol 67:350–358PubMed
14.
go back to reference Sung PS, Yeh CC, Wang LC et al (2017) Increased risk of dementia in patients with non-apnea sleep disorder. Curr Alzheimer Res 14:309–316PubMed Sung PS, Yeh CC, Wang LC et al (2017) Increased risk of dementia in patients with non-apnea sleep disorder. Curr Alzheimer Res 14:309–316PubMed
15.
go back to reference Tsai MC, Tsai KJ, Wang HK et al (2014) Mood disorders after traumatic brain injury in adolescents and young adults: a nationwide population-based cohort study. J Pediatr 164(136–141):e131 Tsai MC, Tsai KJ, Wang HK et al (2014) Mood disorders after traumatic brain injury in adolescents and young adults: a nationwide population-based cohort study. J Pediatr 164(136–141):e131
16.
go back to reference Huang CY, Li YC, Wang HK et al (2015) Stroke suggests increased risk of dementia. Curr Alzheimer Res 12:287–295CrossRefPubMed Huang CY, Li YC, Wang HK et al (2015) Stroke suggests increased risk of dementia. Curr Alzheimer Res 12:287–295CrossRefPubMed
17.
go back to reference Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1–133CrossRefPubMedPubMedCentral Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1–133CrossRefPubMedPubMedCentral
18.
go back to reference Reverter JL, Holgado S, Alonso N et al (2005) Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma. Endocr Relat Cancer 12:973–981CrossRefPubMed Reverter JL, Holgado S, Alonso N et al (2005) Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma. Endocr Relat Cancer 12:973–981CrossRefPubMed
19.
go back to reference Cavalli L, Guazzini A, Cianferotti L et al (2016) Prevalence of osteoporosis in the Italian population and main risk factors: results of BoneTour Campaign BMC. Musculoskelet Disord 17:396CrossRef Cavalli L, Guazzini A, Cianferotti L et al (2016) Prevalence of osteoporosis in the Italian population and main risk factors: results of BoneTour Campaign BMC. Musculoskelet Disord 17:396CrossRef
20.
go back to reference Nguyen ND, Frost SA, Center JR et al (2008) Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int 19:1431–1444CrossRefPubMed Nguyen ND, Frost SA, Center JR et al (2008) Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int 19:1431–1444CrossRefPubMed
21.
go back to reference Hernlund E, Svedbom A, Ivergard M, et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136 Hernlund E, Svedbom A, Ivergard M, et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136
22.
go back to reference Khadilkar AV, Mandlik RM (2015) Epidemiology and treatment of osteoporosis in women: an Indian perspective. Int J Women’s Health 7:841–850CrossRef Khadilkar AV, Mandlik RM (2015) Epidemiology and treatment of osteoporosis in women: an Indian perspective. Int J Women’s Health 7:841–850CrossRef
23.
go back to reference Diamond T, Nery L, Hales I (1991) A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma. J Clin Endocrinol Metab 72:1184–1188CrossRefPubMed Diamond T, Nery L, Hales I (1991) A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma. J Clin Endocrinol Metab 72:1184–1188CrossRefPubMed
24.
go back to reference Garton M, Reid I, Loveridge N et al (1994) Bone mineral density and metabolism in premenopausal women taking L-thyroxine replacement therapy. Clin Endocrinol 41:747–755CrossRef Garton M, Reid I, Loveridge N et al (1994) Bone mineral density and metabolism in premenopausal women taking L-thyroxine replacement therapy. Clin Endocrinol 41:747–755CrossRef
Metadata
Title
Is Partial or Total Thyroidectomy Associated with Risk of Long-Term Osteoporosis: A Nationwide Population-Based Study
Authors
Chien-Ling Hung
Chih-Ching Yeh
Pi-Shan Sung
Chung-Jye Hung
Chih-Hsin Muo
Fung-Chang Sung
I-Ming Jou
Kuen-Jer Tsai
Publication date
01-09-2018
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 9/2018
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-018-4573-2

Other articles of this Issue 9/2018

World Journal of Surgery 9/2018 Go to the issue

Innovative Surgical Techniques Around the World

Anoplasty for Post-hemorrhoidectomy Low Anal Stenosis: A New Technique